Life Science | pharmaphorum

Skip to main content

Wednesday 24 April 2024

twitter linkedin facebook rss

User account menu

Sign up

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

close

Channels

Content type

Categories

Categories

Sort by

Order

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

Sign up

twitter linkedin facebook rss

Sign in

Life Science

Digital

pharmaphorum podcast episode 99a

Retaining the human element of AI within pharma and healthca...

Artificial intelligence (AI) has been the word of 2023, but aside from the promises, what are the realities of its practical implementation in the life sciences setting?

News

UK life sciences

Biotech investment in UK ticks up in Q2

Despite the economic downturn, UK life sciences companies raised a healthy £382 million ($486 million) in new financing in the second quarter of the year, with venture cap

Events

Treg LinkedIn banners (14)

Partner Content

The 3rd Annual RNAi – Based Therapeutics Summit Returns!

successfully develop targeted extrahepatic RNAi drugs

Partner Content

Richard-Adams-Chief-Executive-Officer-PRISYM-ID169web

Partner Content

PRISYM ID announces six further projects go live

PRISYM ID has six new labeling software systems

Events

c893_banner_667x210rev3

Partner Content

4th Life Science Knowledge Management Summit

The only KM event expressly for the Life Sciences

Editor's Picks

Ipsen signs $1.8bn RNA drug alliance with Skyhawk

Metsera lands with $290m to take on obesity giants

Regeneron launches $500m venture capital arm

Telehealth firm Cerebral faces $7m FTC fine over privacy

GSK trails after Pfizer in 5-in-1 meningococcal vaccine race

News

Novartis chief executive Vas Narasimhan

Novartis names ex-BMS CEO Caforio as chair amid strong Q1

Novartis has posted a healthy rise in sales and profits in the first full quarter since it separated from Sandoz and proposed former Bristol Myers Squibb’s chief executive

Digital

pharmaphorum podcast episode 121

Fixing clinical trial data management

It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

rss facebook linkedin twitter

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2024, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – a Healthware Group company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2024, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – a Healthware Group company